Home › T-Cell Lymphoma › Colorado › Denver
T-Cell Lymphoma clinical trials in Denver, CO
3 studies for T-Cell Lymphoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
MB-105 in Patients With CD5 Positive T-cell Lymphoma
RecruitingPhase 2
- SCRI - Colorado Blood Cancer Institute (CBCI), Denver
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital Colorado, Denver
T-Cell Lymphoma trials in other cities
- New York City, NY13 studies
- Philadelphia, PA10 studies
- Baldwin Park, CA9 studies
- Boston, MA9 studies
- Houston, TX8 studies
- Atlanta, GA7 studies
- Rochester, MN6 studies
- Seattle, WA6 studies
- Columbus, OH6 studies
- Chicago, IL6 studies
- New Haven, CT5 studies
- Miami, FL5 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.